FDA Inspection 1208142 — AmerisourceBergen Drug Corp.

AmerisourceBergen Drug Corp. — FEI 3007181228

The FDA completed an inspection of AmerisourceBergen Drug Corp. on Jun 15, 2023 in Morrisville, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 15, 2023
Fiscal Year
2023
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Morrisville, NC (United States)

Citations

IDCFRDescription
1564121 CFR 111.453Written procedures - holding
1589721 CFR 111.83(a)Reserve sample - collect, hold
1600021 CFR 111.130Quality control operations - returned dietary supplement
1604221 CFR 111.503Written procedures - returned dietary supplement

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.